Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH‐secreting pituitary adenoma cells in vitro
- 16 June 2003
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 59 (1), 115-128
- https://doi.org/10.1046/j.1365-2265.2003.01811.x
Abstract
Objective Somatostatin is an endogenous inhibitor of hormone secretion and cell proliferation. Treatment with somatostatin analogues in humans causes a reduction in size and secretory activity of endocrine tumours, including GH‐secreting pituitary adenomas. This study was aimed to characterize the intracellular mechanisms mediating the in vitro antiproliferative and antisecretory effects of somatostatin and its analogue lanreotide, on primary cultures of GH‐secreting pituitary adenoma cells. design Thirteen GH‐secreting pituitary adenoma postsurgical specimens were analysed for somatostatin receptor (SSTR) mRNA expression and a subset of them was analysed in vitro for the effect of somatostatin on cell proliferation, assessed by means of [3H]‐thymidine uptake, and GH release, using an immunoradiometric assay. Moreover, the intracellular signalling involved in such effects has been studied. results All the adenomas analysed expressed at least one somatostatin receptor subtype mRNA. SSTR2 mRNA was identified in 77% of the adenomas, SSTR1 and SSTR3 in 69% and SSTR5 in 60%. Somatostatin and lanreotide inhibited cell proliferation in phorbol ester (PMA)‐stimulated conditions (10/13 adenomas), as well as after fetal calf serum (3/3 adenomas) or IGF‐I stimulation (2/2 adenomas). Conversely, GHRH or forskolin treatments did not significantly affect DNA synthesis in adenoma cells in the presence or absence of somatostatin (2/2 and 4/4 adenomas, respectively). Vanadate pretreatment reversed somatostatin inhibition of PMA‐induced DNA synthesis suggesting an involvement of tyrosine phosphatase in this effect (2/2 adenomas); this was confirmed by the direct induction of tyrosine phosphatase activity in two adenomas after somatostatin treatment. Somatostatin and also lanreotide caused significant inhibition of phorbol ester, forskolin, GHRH and KCl‐dependent increase of GH secretion in the culture medium. Moreover, voltage‐sensitive calcium channel activity induced by 40 mm KCl depolarization in microfluorimetric analysis, was significantly reduced (5/5 adenomas). conclusions These data show that somatostatin and lanreotide inhibit human GH‐secreting pituitary adenoma cell proliferation and hormone release in vitro, and suggest that the activation of tyrosine phosphatases may represent intracellular signals mediating the antiproliferative effects and that the inhibition of the voltage‐dependent calcium channels and adenylyl cyclase activities may control GH secretion.Keywords
This publication has 52 references indexed in Scilit:
- Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for AcromegalyJournal of Clinical Endocrinology & Metabolism, 1998
- Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegalyJournal of Neurosurgery, 1998
- Current Treatment Guidelines for AcromegalyJournal of Clinical Endocrinology & Metabolism, 1998
- Intracellular calcium ion responses to somatostatin in cells from human somatotroph adenomasClinical Endocrinology, 1997
- Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptorsJournal of Molecular Endocrinology, 1996
- Somatostatin receptor subtype gene expression in pituitary adenomasJournal of Clinical Endocrinology & Metabolism, 1995
- Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineageJournal of Clinical Endocrinology & Metabolism, 1994
- AcromegalyNew England Journal of Medicine, 1990
- Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadateBiochemical and Biophysical Research Communications, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976